Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suzetrigine vs Oxycodone for Postoperative Pain After Total Knee Arthroplasty
NCT07219888Phase 4Enrolling by invitation
- Sponsor
- University of Louisville
- Start
- Feb 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of suzetrigine in postoperative pain (2 arms), sponsored by University of Louisville. Primary endpoints: Daily Opioid Use POD 1-14 at 2 weeks, Total opioid usage over two weeks at 2 weeks and 3 more. Started Feb 2026; status: enrolling by invitation.
02
Drugs
suzetrigine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07219888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07219888.